Loading…
The merger will result in ClearOne becoming a wholly owned subsidiary of Vivani Medical, Inc.
ClearOne, Inc. (Nasdaq: CLRO) announced on July 02, 2026, that it has entered into a definitive agreement and plan of merger with Cortigent, Inc., a wholly owned subsidiary of Vivani Medical, Inc. Under the terms of the agreement, ClearOne will become a wholly owned subsidiary of Vivani Medical, Inc.
The transaction involves the issuance of 12,500,000 shares by ClearOne to Vivani Medical, Inc. Post-merger, Vivani Medical, Inc. is expected to hold between 59.4% and 67.5% of the combined entity, while existing ClearOne shareholders will retain between 12.7% and 14.4% ownership. The deal value is estimated to be between a minimum of $10,000,000 and a maximum of $15,000,000.
As of the announcement, ClearOne had a free float of 1,591,487 shares and 2,675,412 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.